University of California1d
Breast cancer treatment advances with light-activated ‘smart bomb’
It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...
Immunotherapy reduces sunspots by 65% in cancer patients
University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...
Why is TikTok’s tan line trend so dangerous — and so popular?
The skincare obsessed generation is seemingly undoing all their work for a temporary, killer glow. We unpack Australia's ...
verywellhealth10d
How to Recognize and Treat a Sun Rash
A sun rash is an immune system reaction to sunlight exposure that causes itchy bumps, raised patches, or blisters on your ...
Morningstar14d
Roche Gets FDA Approval for Breast Cancer Test
Roche Holding said the U.S. Food and Drug Administration approved a test to identify patients with a specific type of breast cancer. The Swiss pharmaceutical company said the FDA backed a label ...
pharmaphorum16d
FDA clears Dupixent as first drug for rare skin disorder
Sanofi and Regeneron have claimed the first approval in the US for a drug for prurigo nodularis, after the FDA gave a green light to Dupixent as a treatment for adults with the rare skin disease ...
Nasdaq18d
FDA Approves AstraZeneca And Daiichi Sankyo's ENHERTU For HER2-Low/Ultralow Breast Cancer
breast cancer, as determined by a Food and Drug Administration (FDA)-approved test, that has progressed on one or more endocrine therapies in the metastatic setting. ENHERTU is a specifically ...
NBC News23d
Federal regulations paused, halting FDA's proposed ban on formaldehyde in hair products
The Food and Drug Administration announced it would decide ... Black women ages 35 to 74 that show a prevalence of uterine cancer among those who used hair relaxers more than twice a year for ...
News Medical24d
Single dose of novel drug shows tumor-clearing potential in breast cancer models
Despite significant therapeutic advances, breast cancer remains a leading cause of ... They acknowledge the need for more testing to confirm drug safety and efficacy, but they suggest if these ...
Popular Science24d
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
STAT24d
Pharmalittle: We’re reading about a cancer therapy’s gold rush, FDA warning Sanofi, and more news
making it the top-selling drug in the world, STAT explains. Experts say a certain type of bispecific antibody seems to have hit upon a crucial combination of two cancer targets: the proteins VEGF ...
UPI24d
FDA approves Spravato, first monotherapy nasal spray to treat depression
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...